Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

BACKGROUND AND AIMS: The pharmacokinetics (PK) and single-dose tolerability of tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist being developed for once-weekly treatment of type 2 diabetes (T2D), weight management, and nonalcoholic steatoh...

Descripción completa

Detalles Bibliográficos
Autores principales: Urva, Shweta, Quinlan, Tonya, Landry, John, Martin, Jennifer, Loghin, Corina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332596/
https://www.ncbi.nlm.nih.gov/pubmed/33778934
http://dx.doi.org/10.1007/s40262-021-01012-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332596/
https://www.ncbi.nlm.nih.gov/pubmed/33778934
http://dx.doi.org/10.1007/s40262-021-01012-2

Ejemplares similares